Cargando…
Circulating Tumor Cells as a Tool of Minimal Residual Disease Can Predict Lung Cancer Recurrence: A longitudinal, Prospective Trial
Background: The role of circulating tumor cells (CTCs) for predicting the recurrence of cancer in lung cancer patients after surgery remains unclear. Methods: A negatively selected protocol of CTC identification was applied. For all the enrolled patients, CTC testing was performed before and after s...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151004/ https://www.ncbi.nlm.nih.gov/pubmed/32155787 http://dx.doi.org/10.3390/diagnostics10030144 |
_version_ | 1783521149658857472 |
---|---|
author | Wu, Ching-Yang Lee, Chia-Lin Wu, Ching-Feng Fu, Jui-Ying Yang, Cheng-Ta Wen, Chi-Tsung Liu, Yun-Hen Liu, Hui-Ping Hsieh, Jason Chia-Hsun |
author_facet | Wu, Ching-Yang Lee, Chia-Lin Wu, Ching-Feng Fu, Jui-Ying Yang, Cheng-Ta Wen, Chi-Tsung Liu, Yun-Hen Liu, Hui-Ping Hsieh, Jason Chia-Hsun |
author_sort | Wu, Ching-Yang |
collection | PubMed |
description | Background: The role of circulating tumor cells (CTCs) for predicting the recurrence of cancer in lung cancer patients after surgery remains unclear. Methods: A negatively selected protocol of CTC identification was applied. For all the enrolled patients, CTC testing was performed before and after surgery on the operation day (day 0), postoperative day 1, and day 3. The daily decline and trend of CTCs were analyzed to correlate with cancer relapse. The mixed model repeated measures (MMRM) adjusted by cancer characteristics was applied for statistical significance. Results: Fifty patients with lung mass undergoing surgery were enrolled. Among 41 primary lung cancers, 26 (63.4%) were pathological stage Tis and I. A total of 200 CTC tests were performed. MMRM analysis indicated that surgery could contribute to a CTC decline after surgery in all patients with statistical significance (p = 0.0005). The daily decrease of CTCs was statistically different between patients with and without recurrence (p = 0.0068). An early rebound of CTC counts on postoperative days 1 and 3 was associated with recurrence months later. Conclusion: CTC testing can potentially serve as a tool for minimal residual disease detection in early-staged lung cancer after curative surgery. |
format | Online Article Text |
id | pubmed-7151004 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71510042020-04-20 Circulating Tumor Cells as a Tool of Minimal Residual Disease Can Predict Lung Cancer Recurrence: A longitudinal, Prospective Trial Wu, Ching-Yang Lee, Chia-Lin Wu, Ching-Feng Fu, Jui-Ying Yang, Cheng-Ta Wen, Chi-Tsung Liu, Yun-Hen Liu, Hui-Ping Hsieh, Jason Chia-Hsun Diagnostics (Basel) Article Background: The role of circulating tumor cells (CTCs) for predicting the recurrence of cancer in lung cancer patients after surgery remains unclear. Methods: A negatively selected protocol of CTC identification was applied. For all the enrolled patients, CTC testing was performed before and after surgery on the operation day (day 0), postoperative day 1, and day 3. The daily decline and trend of CTCs were analyzed to correlate with cancer relapse. The mixed model repeated measures (MMRM) adjusted by cancer characteristics was applied for statistical significance. Results: Fifty patients with lung mass undergoing surgery were enrolled. Among 41 primary lung cancers, 26 (63.4%) were pathological stage Tis and I. A total of 200 CTC tests were performed. MMRM analysis indicated that surgery could contribute to a CTC decline after surgery in all patients with statistical significance (p = 0.0005). The daily decrease of CTCs was statistically different between patients with and without recurrence (p = 0.0068). An early rebound of CTC counts on postoperative days 1 and 3 was associated with recurrence months later. Conclusion: CTC testing can potentially serve as a tool for minimal residual disease detection in early-staged lung cancer after curative surgery. MDPI 2020-03-06 /pmc/articles/PMC7151004/ /pubmed/32155787 http://dx.doi.org/10.3390/diagnostics10030144 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wu, Ching-Yang Lee, Chia-Lin Wu, Ching-Feng Fu, Jui-Ying Yang, Cheng-Ta Wen, Chi-Tsung Liu, Yun-Hen Liu, Hui-Ping Hsieh, Jason Chia-Hsun Circulating Tumor Cells as a Tool of Minimal Residual Disease Can Predict Lung Cancer Recurrence: A longitudinal, Prospective Trial |
title | Circulating Tumor Cells as a Tool of Minimal Residual Disease Can Predict Lung Cancer Recurrence: A longitudinal, Prospective Trial |
title_full | Circulating Tumor Cells as a Tool of Minimal Residual Disease Can Predict Lung Cancer Recurrence: A longitudinal, Prospective Trial |
title_fullStr | Circulating Tumor Cells as a Tool of Minimal Residual Disease Can Predict Lung Cancer Recurrence: A longitudinal, Prospective Trial |
title_full_unstemmed | Circulating Tumor Cells as a Tool of Minimal Residual Disease Can Predict Lung Cancer Recurrence: A longitudinal, Prospective Trial |
title_short | Circulating Tumor Cells as a Tool of Minimal Residual Disease Can Predict Lung Cancer Recurrence: A longitudinal, Prospective Trial |
title_sort | circulating tumor cells as a tool of minimal residual disease can predict lung cancer recurrence: a longitudinal, prospective trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151004/ https://www.ncbi.nlm.nih.gov/pubmed/32155787 http://dx.doi.org/10.3390/diagnostics10030144 |
work_keys_str_mv | AT wuchingyang circulatingtumorcellsasatoolofminimalresidualdiseasecanpredictlungcancerrecurrencealongitudinalprospectivetrial AT leechialin circulatingtumorcellsasatoolofminimalresidualdiseasecanpredictlungcancerrecurrencealongitudinalprospectivetrial AT wuchingfeng circulatingtumorcellsasatoolofminimalresidualdiseasecanpredictlungcancerrecurrencealongitudinalprospectivetrial AT fujuiying circulatingtumorcellsasatoolofminimalresidualdiseasecanpredictlungcancerrecurrencealongitudinalprospectivetrial AT yangchengta circulatingtumorcellsasatoolofminimalresidualdiseasecanpredictlungcancerrecurrencealongitudinalprospectivetrial AT wenchitsung circulatingtumorcellsasatoolofminimalresidualdiseasecanpredictlungcancerrecurrencealongitudinalprospectivetrial AT liuyunhen circulatingtumorcellsasatoolofminimalresidualdiseasecanpredictlungcancerrecurrencealongitudinalprospectivetrial AT liuhuiping circulatingtumorcellsasatoolofminimalresidualdiseasecanpredictlungcancerrecurrencealongitudinalprospectivetrial AT hsiehjasonchiahsun circulatingtumorcellsasatoolofminimalresidualdiseasecanpredictlungcancerrecurrencealongitudinalprospectivetrial |